
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4745301
[patent_doc_number] => 20080089903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'CD4+T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES'
[patent_app_type] => utility
[patent_app_number] => 11/837953
[patent_app_country] => US
[patent_app_date] => 2007-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4461
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089903.pdf
[firstpage_image] =>[orig_patent_app_number] => 11837953
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/837953 | CD4+T-LYMPHOCYTE-SPECIFIC HEPATITIS C VIRUS EPITOPES | Aug 12, 2007 | Abandoned |
Array
(
[id] => 5271601
[patent_doc_number] => 20090075377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'MOLECULAR INTERACTIONS IN CELLS'
[patent_app_type] => utility
[patent_app_number] => 11/833848
[patent_app_country] => US
[patent_app_date] => 2007-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 59941
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075377.pdf
[firstpage_image] =>[orig_patent_app_number] => 11833848
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/833848 | MOLECULAR INTERACTIONS IN CELLS | Aug 2, 2007 | Abandoned |
Array
(
[id] => 6070087
[patent_doc_number] => 20110044937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/375361
[patent_app_country] => US
[patent_app_date] => 2007-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14546
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20110044937.pdf
[firstpage_image] =>[orig_patent_app_number] => 12375361
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375361 | STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY | Jul 26, 2007 | Abandoned |
Array
(
[id] => 4797436
[patent_doc_number] => 20080009022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Immunization of dairy cattle with chimeric gapC protein against streptococcus infection'
[patent_app_type] => utility
[patent_app_number] => 11/825796
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 18074
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11825796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/825796 | Immunization of dairy cattle with chimeric gapC protein against streptococcus infection | Jul 8, 2007 | Abandoned |
Array
(
[id] => 4964867
[patent_doc_number] => 20080107687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'FELINE VACCINES AGAINST AVIAN INFLUENZA'
[patent_app_type] => utility
[patent_app_number] => 11/767276
[patent_app_country] => US
[patent_app_date] => 2007-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 28740
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107687.pdf
[firstpage_image] =>[orig_patent_app_number] => 11767276
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/767276 | FELINE VACCINES AGAINST AVIAN INFLUENZA | Jun 21, 2007 | Abandoned |
Array
(
[id] => 5392154
[patent_doc_number] => 20090209467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'VIRAL CAPSID PROTEINS AND ANY PEPTIDES OR COMPOSITIONS THEREOF FOR THE TREATMENT OF PATHOLOGIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/305323
[patent_app_country] => US
[patent_app_date] => 2007-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12445
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12305323
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305323 | Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders | Jun 17, 2007 | Issued |
Array
(
[id] => 4797873
[patent_doc_number] => 20080009459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences'
[patent_app_type] => utility
[patent_app_number] => 11/818873
[patent_app_country] => US
[patent_app_date] => 2007-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14260
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009459.pdf
[firstpage_image] =>[orig_patent_app_number] => 11818873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/818873 | Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences | Jun 14, 2007 | Abandoned |
Array
(
[id] => 4657135
[patent_doc_number] => 20080025996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Methods and Compositions Comprising Polycationic Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/757007
[patent_app_country] => US
[patent_app_date] => 2007-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6121
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20080025996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11757007
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/757007 | Methods and Compositions Comprising Polycationic Compounds | May 31, 2007 | Abandoned |
Array
(
[id] => 4670397
[patent_doc_number] => 20080045457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Ancestral Hepatitis C virus envelope protein sequence'
[patent_app_type] => utility
[patent_app_number] => 11/809365
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15831
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045457.pdf
[firstpage_image] =>[orig_patent_app_number] => 11809365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/809365 | Ancestral Hepatitis C virus envelope protein sequence | May 30, 2007 | Abandoned |
Array
(
[id] => 5045600
[patent_doc_number] => 20070264273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/746415
[patent_app_country] => US
[patent_app_date] => 2007-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23818
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264273.pdf
[firstpage_image] =>[orig_patent_app_number] => 11746415
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/746415 | SPHINGOID POLYALKLAMINE CONJUGATES, ISOMERS AND USES THEREOF | May 8, 2007 | Abandoned |
Array
(
[id] => 6632718
[patent_doc_number] => 20100173387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'METHOD FOR PRODUCING ADENOVIRUS VECTORS FOR GENE THERAPY AND DNA SEQUENCES USED THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/298583
[patent_app_country] => US
[patent_app_date] => 2007-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18222
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173387.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298583
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298583 | METHOD FOR PRODUCING ADENOVIRUS VECTORS FOR GENE THERAPY AND DNA SEQUENCES USED THEREFOR | Apr 26, 2007 | Abandoned |
Array
(
[id] => 6302436
[patent_doc_number] => 20100068224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Method for Producing Viral Vaccine and Therapeutic Peptide Antigens'
[patent_app_type] => utility
[patent_app_number] => 12/297162
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22241
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068224.pdf
[firstpage_image] =>[orig_patent_app_number] => 12297162
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/297162 | Method for Producing Viral Vaccine and Therapeutic Peptide Antigens | Apr 23, 2007 | Abandoned |
Array
(
[id] => 174001
[patent_doc_number] => 07659380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Method of isolation and purification of trypsin from pronase protease and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/788714
[patent_app_country] => US
[patent_app_date] => 2007-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9420
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/659/07659380.pdf
[firstpage_image] =>[orig_patent_app_number] => 11788714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/788714 | Method of isolation and purification of trypsin from pronase protease and use thereof | Apr 19, 2007 | Issued |
Array
(
[id] => 4669373
[patent_doc_number] => 20080044433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Epitopes of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 11/786414
[patent_app_country] => US
[patent_app_date] => 2007-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15155
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044433.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786414
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786414 | Epitopes of hepatitis C virus | Apr 9, 2007 | Abandoned |
Array
(
[id] => 5199092
[patent_doc_number] => 20070298410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Assay to detect HCV receptor binding'
[patent_app_type] => utility
[patent_app_number] => 11/784521
[patent_app_country] => US
[patent_app_date] => 2007-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5962
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11784521
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/784521 | Assay to detect HCV receptor binding | Apr 5, 2007 | Abandoned |
Array
(
[id] => 6451006
[patent_doc_number] => 20100280268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/293589
[patent_app_country] => US
[patent_app_date] => 2007-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35410
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293589
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293589 | HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM | Apr 5, 2007 | Abandoned |
Array
(
[id] => 4681816
[patent_doc_number] => 20080248042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc'
[patent_app_type] => utility
[patent_app_number] => 11/783297
[patent_app_country] => US
[patent_app_date] => 2007-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7810
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248042.pdf
[firstpage_image] =>[orig_patent_app_number] => 11783297
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/783297 | Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc | Apr 4, 2007 | Abandoned |
Array
(
[id] => 4803550
[patent_doc_number] => 20080015139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Soluble virus-specific T-cell receptor compositions'
[patent_app_type] => utility
[patent_app_number] => 11/784277
[patent_app_country] => US
[patent_app_date] => 2007-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4464
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015139.pdf
[firstpage_image] =>[orig_patent_app_number] => 11784277
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/784277 | Soluble virus-specific T-cell receptor compositions | Apr 4, 2007 | Abandoned |
Array
(
[id] => 7511667
[patent_doc_number] => 20110257377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Covalently linked complexes of HIV TAT and ENV PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/225655
[patent_app_country] => US
[patent_app_date] => 2007-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15046
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225655 | Covalently linked complexes of HIV TAT and ENV PROTEINS | Mar 26, 2007 | Abandoned |
Array
(
[id] => 4839407
[patent_doc_number] => 20080279892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Recombinant RSV Virus Expression Systems And Vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/690957
[patent_app_country] => US
[patent_app_date] => 2007-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 34626
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11690957
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/690957 | Recombinant RSV Virus Expression Systems And Vaccines | Mar 25, 2007 | Abandoned |